Kuwano A, Yada M, Tanaka K, Hamomoto T, et al. Cost-effectiveness Analysis of Atezolizumab Plus Bevacizumab Versus Lenvatinib in Intermediate-stage Hepatocellular Carcinoma: A Real-world Retrospective Study. Anticancer Res 2025;45:4627-4636.
PMID: 41006019